By suppressing phosphoglycerate mutase 1 (PGAM1), the downregulation of lipocalin-2 (LCN2) promotes ferroptosis in hepatocellular carcinoma cells and facilitates the recruitment of CD8+ T cells. This evidence concerns the gene LCN2 and hepatocellular carcinoma.